Limitations and improvements of the revised tumor node metastasis (TNM) staging system of clear cell renal cell carcinoma

Ming-cong ZHANG,Shang-qian WANG,Li-jiang SUN,Li CUI,Xin MAO,Qiang CAO,Pu LI,Peng-fei SHAO,Chao QIN,Li-xin HUA,Chang-jun YIN

DOI: https://doi.org/10.3969/j.issn.1009-8291.2015.05.003

2015-01-01

Abstract:ABSTRACT:Objective To evaluate whether the revised 2010 Tumor Node Metastasis (TNM) staging system could lead to a more accurate prediction of the prognosis of renal cell carcinoma (RCC) .Methods A total of 1 ,216 patients who had un‐dergone radical or partial nephrectomy for RCC during 2003 and 2011 were enrolled .All patients had pathologically confirmed clear cell RCC (ccRCC) .All cases were staged by 2010 TNM staging systems after pathological review ,and survival data were collected .Univariate and multivariate Cox regression models were used to evaluate cancer‐specific survival (CSS) and progres‐sion‐free survival (PFS) after surgery .Continuous variables ,such as age and tumor diameter ,were calculated as mean values and standard deviations (s .d .) or as median values .Survival rates were calculated with Kaplan‐Meier method ,and differences were assessed with log‐rank tests .Results When using the revised 2010 staging system ,we found that more than 92% of pa‐tients with T3 tumors were staged in the T3a subgroup ,and their survival rates were not significantly different from those of patients with T2b tumors .In addition ,T2 subclassification failed to independently predict the survival rate for RCC patients . When we used the size of tumor and site of invasion to subgroup the T3a patients ,the prognosis of RCC patients could be evalu‐ated more accurately .Conclusion There will be better prognosis if T3a patients are subgrouped by the size of tumor and site of invasion .We need more clinical data to identify the difference in survival rates between the T2a and T2b subgroups .